Elgemtumab
Elgemtumab Basic information
- Product Name:
- Elgemtumab
- Synonyms:
-
- Elgemtumab
- Research Grade Elgemtumab (DHD48401)
- Research Grade Elgemtumab
- Elgemtumab (anti-ERBB3)
- CAS:
- 1512559-37-3
- MW:
- 0
- Mol File:
- Mol File
Elgemtumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Elgemtumab Usage And Synthesis
Uses
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential[1].
in vivo
Elgemtumab(LJM716)(i.v., 20 mg/kg,once) can reduce pHER3 by 52% and pAKT by 84% in SCID mice with BT474 breast cancer xenografts; while in BxPC-3 pancreatic xenografts In SCID mice, it resulted in a maximum inhibition of pHER3 of 86% and a maximum inhibition of pAKT of 74%[1].
Elgemtumab (LJM716) (20 mg/kg, every other day, 35 days) slows tumor growth in NSG mice with BT474 breast cancer xenografts[1].
References
[1] Andrew P Garner, et al. An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin. Cancer Res. 2013 Oct 1;73(19):6024-35. DOI:10.1158/0008-5472.CAN-13-1198
ElgemtumabSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15817493340
- 981810490@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com